November 15, 2025

AI Models Predict CNS Tumors From Spinal Fluid

At AMP 2025, a South Korean research team outlined a multimodal approach that integrates CSF, DNA, and MRI data to enable early, noninvasive tumor classification.

Conexiant

November 15, 2025

New Genetic Test Targets Rare X-Linked Movement Disorder

A targeted assay, presented at AMP 2025, identifies disease-specific TAF1 variants that standard panels often miss.

Conexiant

November 15, 2025

Artificial Intelligence in Health Care: The Ethical Frontier

At AMP 2025, Takunda Matose, PhD, urged pathologists to consider the limitations of big data and probabilistic reasoning to maximize AI’s benefits for clinical outcomes.

Conexiant

November 14, 2025

Michael Laposata Receives Champion for Innovation Award

At AMP’s annual meeting, the organization also honored Alexis Carter, Dara Aisner, and Lawrence Jennings for their contributions to laboratory medicine and molecular pathology.

Conexiant

November 14, 2025

Streamlining VUS Classification in Clinical Genomics

New SVCv4 standards and data-sharing initiatives will help laboratories and clinicians focus on actionable variants.

Conexiant

November 13, 2025

Old Cancer Samples Yield New Genetic Insights

A University of Chicago team demonstrates at AMP 2025 that archival pathology samples can reveal cancer’s genetic evolution.

Conexiant

November 13, 2025

Cancer Genomics Pioneer Honored by AMP

In her keynote lecture, Elaine R. Mardis, PhD, discussed advances in pediatric precision medicine and encouraged the expansion of data-sharing initiatives.

Conexiant

November 04, 2025

FDA Approves First Drug for Thymidine Kinase 2 Deficiency

First-ever treatment shows significant survival benefit in matched-pair analysis of this ultra-rare mitochondrial depletion syndrome.

Conexiant

October 31, 2025

What Happens When You Read DNA and RNA Together?

A single-cell DNA–RNA sequencing method connects genetic variation to gene activity in thousands of individual cells

The Pathologist